Trump’s Rhetorical Pivot On Pharma: The Hucksterism Is Still A Threat
• By Michael McCaughan
Pharmaceutical companies had earlier worried that Trump could be too harsh a critic. Now they may worry that the President may oversell their products.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
